Maryland Works to Commercialize 2 Scientific Discoveries
from The Baltimore Sun
The technology transfer arm of the University of Maryland has entered into separate licensing agreements with two Baltimore companies aiming to bring anti-cancer therapies to market. The first agreement by University of Maryland Ventures grants Educational and Scientific LLC the licensing rights to its interest in a molecule whose anti-cancer properties were jointly discovered by the company and the University of Maryland Baltimore.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063